BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22823914)

  • 1. Lactulose in the treatment of hepatic encephalopathy: new evidence for an old modality.
    Jia JD
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1262-3. PubMed ID: 22823914
    [No Abstract]   [Full Text] [Related]  

  • 2. Gut flora and hepatic encephalopathy in patients with cirrhosis.
    Riordan SM; Williams R
    N Engl J Med; 2010 Mar; 362(12):1140-2. PubMed ID: 20335591
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactulose a day keeps encephalopathy at bay.
    Klinken E; MacQuillan G
    J Gastroenterol Hepatol; 2011 Jun; 26(6):939-40. PubMed ID: 21564285
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Agrawal A; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2011 Jun; 26(6):996-1003. PubMed ID: 21129028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding.
    Aires FT; Ramos PT; Bernardo WM
    Rev Assoc Med Bras (1992); 2016; 62(3):243-7. PubMed ID: 27310548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifaximin treatment in hepatic encephalopathy.
    Sharma P; Sharma BC
    N Engl J Med; 2010 Jun; 362(25):2423-4; author reply 2424-5. PubMed ID: 20578274
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatic encephalopathy -- preventative effects of lactulose].
    Z Gastroenterol; 2013 Aug; 51(8):708. PubMed ID: 24298621
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
    Irimia R; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home lactulose enema: prevention of hepatic encephalopathy at home.
    Saito T; Shinzawa H; Watanabe H; Togashi H; Kawata S
    J Gastroenterol; 2002 Jan; 37(1):68-9. PubMed ID: 11824804
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy.
    Horsmans Y; Solbreux PM; Daenens C; Desager JP; Geubel AP
    Aliment Pharmacol Ther; 1997 Feb; 11(1):165-70. PubMed ID: 9042989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy.
    Flamm SL
    Am J Med Sci; 2018 Sep; 356(3):296-303. PubMed ID: 30286824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on management of patients with overt hepatic encephalopathy.
    Chacko KR; Sigal SH
    Hosp Pract (1995); 2013 Aug; 41(3):48-59. PubMed ID: 23948621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acidifying therapy in the combined treatment of patients with liver cirrhosis].
    Chervak IM
    Lik Sprava; 1998; (2):82-5. PubMed ID: 9670665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Old wine in new bottles: Lactulose works in hepatic encephalopathy].
    Bendtsen F
    Ugeskr Laeger; 2016 Oct; 178(42):. PubMed ID: 27745574
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Lactulose in Hepatic Encephalopathy: Is It Time to Shift Targets?
    Sharma S; Chauhan A
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e1220-e1221. PubMed ID: 34058412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.